FLUBLOK QUADRIVALENT 2022-2023 FORMULA

Manufacturer:

Sanofi

Name:

FLUBLOK QUADRIVALENT 2022-2023 FORMULA

HCPCS Code Descriptor:

RIV4 VACC RECOMBINANT DNA IM, 0.5 ML

Category:

CPT Drug Code

HCPCS:

90682

NDC(s):

49281-0722-10, 49281-0722-88

Primary Type:

Vaccine-Flu

Generic/Specialty Status:

Single-Source

Route of Administration:

Intramuscular

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About:

FLUBLOK QUADRIVALENT 2022-2023 FORMULA is a Vaccine-Flu drug manufactured by Sanofi and administered via the Intramuscular route of administration. The CPT Drug Code: 90682 is aligned to the drug FLUBLOK QUADRIVALENT 2022-2023 FORMULA.

Flublok Quadrivalent, also known as a Recombinant flu vaccines, is for active immunization against the influenza virus. Flublok differs from traditional influenza vaccines because it does not use the flu virus or chicken eggs in it's manufacturing process. The Recombinant flu vaccine, along with the cell-based flu vaccine, are the only FDA approved egg-free flu vaccines available in the United States. Flublok Quadrivalent is licensed for use in those 18 years or older, and is preferentially recommended for people 65 years and older.